A FUSION PROTEIN CROSSLINKING FC-EPSILON-RI AND/OR FCEPSILON-RII TO FC-GAMMA-RIIB FOR THE THERAPY OF ATOPIC ASTHMA AND ALLERGY

Details for Australian Patent Application No. 2003269870 (hide)

Owner ABLYNX N.V.

PCT Number PCT/EP03/09134

Filing date 18 August 2003

Event Publications

15 January 2004 Complete Application Filed

11 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(3)/See Reg. 8.3(2). This application was not yet Open to Public Inspection. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003269871-RADIOSENSITIZER COMPOSITION CONTAINING NACETYLPHYTOSPHINGOSINE ANALOGS AND N,N-DIMETHYL-PHYTOSPHINGOSIN E ANALOGS AS THE ACTIVE INGREDIENTS

2003269869-METHODS OF RECEIVING COMMUNICATIONS SIGNALS INCLUDING A PLURALITY OF DIGITAL FILTERS HAVING DIFFERENT BANDWIDTHS AND RELATED RECEIVERS